Thiazolidinedione Monotherapy for T2DM Tied to Lower Dementia Risk
Sulfonylurea monotherapy linked to increased risk for all-cause dementia compared with metformin monotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.